We suggest no antithrombotic therapy for patients with none of the risks outlined in the “CCS algorithm” (age <65 and no CHADS2 risk factors) and free of arterial vascular disease (coronary, aortic, peripheral). (Conditional Recommendation, Low Quality Evidence)